Severe Aplastic Anaemia Working Party (SAAWP)
Type d'étude:
Numéro de l'étude:
8409079
Type de traitement:
Allogeneic - Haploidentical
Maladies:
Bone marrow failure
Titre court:
Haplo-SCT for cBMT
Objectif principal:
To assess the outcome of patients affected by congenital BMF after haploidentical HSCT.
Principaux critères d'inclusion:
Inclusion criteria:
• All congenital BMF syndromes before first haploidentical HSCT
• First haploidentical HSCT between 1990-2019
• Stem cell source: bone marrow or peripheral blood (manipulated or unmanipulated)
• All congenital BMF syndromes before first haploidentical HSCT
• First haploidentical HSCT between 1990-2019
• Stem cell source: bone marrow or peripheral blood (manipulated or unmanipulated)
Pays:
Investigateur principal:
Dr. Stefano Giardino
Coordinateur EBMT de l'étude:
Brian Piepenbroek
E-mail du coordinateur de l'étude:
saawpebmt@lumc.nl